Teva’s $200 Million Global License Agreement With Alder BioPharmaceuticals®

Ambrogio Visconti

Goodwin advised Teva Pharmaceuticals International GmbH., a subsidiary of Teva Pharmaceutical Industries Ltd., on its global license agreement with Alder BioPharmaceuticals. The agreement validates Teva’s IP…

This content is for members only.
Login to Read More Join Now
Print Friendly, PDF & EmailPrintFriendly
Avatar

Author: Ambrogio Visconti

…

This content is for members only.
Login to Read More Join Now
Print Friendly, PDF & EmailPrintFriendly